These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3785356)

  • 1. Psoriasis and Raynaud's phenomenon with antiribonucleoprotein antibodies.
    Kallenberg CG; de Rooij DJ; van Venrooij WJ
    N Engl J Med; 1987 Jan; 316(2):111-2. PubMed ID: 3785356
    [No Abstract]   [Full Text] [Related]  

  • 2. Psoriasis and Raynaud's phenomenon associated with autoantibodies to U1 and U2 small nuclear ribonucleoproteins.
    Reeves WH; Fisher DE; Wisniewolski R; Gottlieb AB; Chiorazzi N
    N Engl J Med; 1986 Jul; 315(2):105-11. PubMed ID: 2941686
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anti-collagen IV antibodies in patients with scleroderma and idiopathic Raynaud's phenomenon].
    Gabrielli A; Montroni M; Rupoli S; Caniglia ML; Danieli G
    Recenti Prog Med; 1985 Jan; 76(1):21-2. PubMed ID: 3991970
    [No Abstract]   [Full Text] [Related]  

  • 4. [Raynaud's phenomenon and anti-centromeric antibodies].
    Marquet R; Villar MM; Ordi J; de la Figuera M; Vilardell M
    Med Clin (Barc); 1984 Jun; 83(3):129-30. PubMed ID: 6482556
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoantibodies to the URNP particles: relationship to clinical diagnosis and nephritis.
    Reichlin M; Van Venrooij WJ
    Clin Exp Immunol; 1991 Feb; 83(2):286-90. PubMed ID: 1825188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic abnormalities in idiopathic Raynaud's phenomenon.
    Moutsopoulos HM; Constantopoulos S; Gerber LH; Lawley TJ
    Clin Exp Rheumatol; 1983; 1(1):45-8. PubMed ID: 6681124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticentromere antibody and Raynaud's phenomenon.
    Czirják L; Schlammadinger J; Szegedi G
    Dermatologica; 1991; 183(1):55. PubMed ID: 1769420
    [No Abstract]   [Full Text] [Related]  

  • 8. Frequency and clinical significance of anti-RNP antibodies in Italian SLE patients.
    Montecucco C; Caporali R; Ravelli A; Ronchetti A; Rossi S; Martini A; Notario A
    Ann Ital Med Int; 1994; 9(1):12-5. PubMed ID: 8003386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Raynaud's phenomenon. Practical considerations on the forms secondary to immunomediated systemic diseases].
    Marcolongo R; Corà F; Laveder F; Cavallo M; Busato A; Rigoli AM
    Minerva Med; 1997; 88(7-8):307-10. PubMed ID: 9304074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein.
    Maddison PJ; Mogavero H; Reichlin M
    J Rheumatol; 1978; 5(4):407-11. PubMed ID: 310884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The anti-synthetase syndrome: muscle disease and multisystem disorder at the same time].
    Hengstman GJ; van Venrooij WJ; van den Hoogen FH; van Engelen BG
    Ned Tijdschr Geneeskd; 2003 Aug; 147(31):1485-9. PubMed ID: 12924076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raynaud's features in childhood. Clinical, immunological and capillaroscopic study.
    Navon P; Yarom A; Davis E
    J Mal Vasc; 1992; 17(4):273-6. PubMed ID: 1494054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon by nailfold videocapillaroscopy: comment on the article by Hirschl et al.
    Cutolo M; Pizzorni C; Sulli A
    Arthritis Rheum; 2007 Jun; 56(6):2102-3; author reply 2103-4. PubMed ID: 17530659
    [No Abstract]   [Full Text] [Related]  

  • 14. Raynaud's phenomenon and initially seronegative mixed connective tissue disease.
    Ellman MH; Pachman L; Medof ME
    J Rheumatol; 1981; 8(4):632-4. PubMed ID: 6975377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to the nucleolar organizer antigen NOR-90 in children with systemic rheumatic diseases.
    Fritzler MJ; von Muhlen CA; Toffoli SM; Staub HL; Laxer RM
    J Rheumatol; 1995 Mar; 22(3):521-4. PubMed ID: 7783073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune complexes in peripheral blood polymorphonuclear leucocytes of patients with Raynaud's phenomenon.
    van der Maulen J; Wouda AA; Mandema E; The TH
    Clin Exp Immunol; 1979 Jan; 35(1):62-6. PubMed ID: 428147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological arguments for classifying Raynaud's phenomenon as idiopathic.
    Gentric A; Blaschek MA; Le Noach JF; Johanet C; Jouquan J; Lamour A; Abuaf N; Pennec YL; Youinou P
    J Rheumatol; 1990 Sep; 17(9):1177-81. PubMed ID: 2290158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic (im)possibilities in Raynaud's phenomenon].
    Jager J
    Ned Tijdschr Geneeskd; 1996 May; 140(19):1044. PubMed ID: 8684503
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti blood group-M autoantibodies with livedo reticularis, Raynaud's phenomenon, and anaemia.
    Sangster JM; Kenwright MG; Walker MP; Pembroke AC
    J Clin Pathol; 1979 Feb; 32(2):154-7. PubMed ID: 438345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Raynaud's phenomenon and anticentromere antibodies].
    Marquet Palomer R; Vilardell Tarrés M; Ordi Ros J
    Med Clin (Barc); 1987 Nov; 89(17):721-4. PubMed ID: 3501051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.